Cyclin A is essential for regulating key transitions in the eukaryotic cell cycle including initiation of DNA replication and mitosis. This paper describes the characterization of a truncated cyclin A isoform (cyclin A t ) in vitro in cultured mammalian cells and in mouse tissues. The presence of cyclin A t in specific cell types correlates with the ability of cell extracts to cleave in vitro translated cyclin A. In CHO-K1 cells, cyclin A processing to cyclin A t occurs at the N terminus; it does not involve the 26 S proteasome, nor could it be induced by conditional overexpression of the cyclin-dependent kinase inhibitor p27 Kip1 . However, high cell densities lead to increased cyclin A t levels. Unlike full-length cyclin A, cyclin A t localizes to the cytoplasm, where it binds Cdk2. The data suggest that cyclin A processing occurs in vivo to yield an N-terminally truncated isoform by an unknown mechanism that is regulated by cell density. Differential subcellular localization may provide the first insights into the physiological role of cyclin A t .
1 promotes cell cycle progression in mammalian cells. Various cyclins bind and activate Cdks at specific times during the cell cycle. Mammalian cyclin A activates Cdk2 in S phase and Cdk1 (Cdc2) in G 2 and M phases (1) (2) (3) (4) . One important mechanism that enables sequential activation of cyclin-Cdk complexes is the periodic synthesis and destruction of cyclins. Cyclin A expression starts late in G 1 phase increasing through S and G 2 phase before the protein is degraded in M phase (2, 3) . During most of G 1 phase, cyclin A expression is transcriptionally repressed via a bipartite negative regulatory element within its promoter region. This repressor module consists of a 5Ј element called a cell cycle-responsive element or cell cycle-dependent element and the 3Ј cell cycle gene homology region (5-7). E2F-containing complexes have been reported to bind cell cycleresponsive/cell cycle-dependent elements, thereby linking regulation of cyclin A transcript levels to the pRb/E2F pathway (6, 8, 9) . Recently, a novel cyclin A 3Ј cell cycle gene homology region binding factor has been described (10) .
Cyclins are usually grouped into G 1 cyclins, such as cyclin E, which controls the G 1 /S transition, and mitotic cyclins, such as cyclin B, which is required for entry into mitosis. Although classified as a mitotic cyclin, cyclin A is the only cyclin known to play essential roles not only in mitosis but also in DNA replication (1) . Cyclin A function is nonredundant, as demonstrated by the embryonic lethality of homozygous null mutations in mice (11) . Cyclin A appears to be rate-limiting for initiation of DNA replication and is specifically localized to nuclear replication foci (12, 13) . Specific inhibition of cyclin A by expression of antisense cyclin A mRNA or microinjection of anti-cyclin A antibodies has been shown to block DNA replication of cultured cells (1, 14, 15) . Furthermore, conditional overexpression of cyclin A led to premature S phase entry of fibroblasts (16) . However, cyclin A has recently been reported to function in sequestering Cdc6, an essential initiator of DNA replication, to the cytoplasm, suggesting a role of cyclin A in preventing re-replication (17) . Injection of cyclin A-specific antibodies after S phase prevented human cells from progressing through mitosis (1) , and in a Drosophila mutant lacking cyclin A, cells arrested in G 2 phase following exhaustion of maternal cyclin A (18, 19). Conversely, microinjection of cyclin A-Cdk2 was shown to drive human G 2 phase cells into mitosis, suggesting that cyclin A-Cdk2 complexes are rate-limiting for entry into mitosis (20) . Furthermore, cyclin A-Cdk2 mediates E2F-induced accumulation of cyclin B during S phase by phosphorylating Cdh1, the activating cyclosome/anaphase-promoting complex (APC) subunit, which provides the first link between the pRb/E2F G 1 phase regulatory network and APC-dependent proteolysis (21) .
Cyclins are degraded at specific points in the cell cycle by ubiquitin-mediated proteolysis. Ubiquitination of proteins targets them to the 26 S proteasome. This requires the orchestrated action of a ubiquitin-activating enzyme (E1), a ubiquitin-conjugating enzyme (E2), and a specificity factor (E3), which confers substrate recognition. Cell cycle-regulatory proteins have been shown to be substrates for two E3 complexes: the APC acting during mitosis and the Skp1-cullin-F-box protein complex, which mainly targets proteins early in the cell cycle (for a review, see Ref. 22) . Mitotic cyclins share a ninebase pair motif called the destruction box, which is required for proteasome-mediated degradation of cyclin B during mitosis (23) . Cyclin A variants containing mutations within the destruction box are not degraded in Xenopus extracts, suggesting a similar role of the conserved motif as in B-type cyclins (24) . However, mitotic degradation of cyclin A-green fluorescent protein fusion proteins was reported to occur independent of the destruction box in HeLa cells. These in vivo data demonstrate that removal of the first 97 amino acids, including the D-box and the adjacent lysine-rich region, is required for stabilization of cyclin A (25) .
Recently, proteolytic cleavage of cyclin A has been reported in vitro in coupled transcription/translation systems using rabbit reticulocyte lysates. These data suggested an involvement of the cyclin-dependent kinase inhibitor p27
Kip1 in N-terminal truncation of cyclin A (26). Here we characterize an N-terminally truncated cyclin A isoform (cyclin A t ) in vitro, in cultured mammalian cells, and in vivo, which is induced by cell density and, unlike full-length cyclin A, localizes to the cytoplasm, where it interacts with Cdk2. In addition, our results indicate that p27
Kip1 is not involved in in vivo processing of cyclin A.
EXPERIMENTAL PROCEDURES
Cell Culture-CHO-K1 Chinese hamster ovary cells (ATCC number CCL-61) were cultured in FMX-8 medium (Dr. Messi, Cell Culture Technologies, Zurich, Switzerland) supplemented with 10% fetal calf serum (PAA Laboratories GmbH, Linz, Austria; lot number A01129-242) and 100 IU/ml penicillin/streptomycin solution (Sigma). Human A431 vulval carcinoma cells, human U2-OS osteogenic sarcoma cells, Hs68 primary human fibroblast (ATCC number CRL-1635), HuT12 transformed human fibroblasts, A549 lung adenocarcinoma cells, PC3 prostatic carcinoma cells, and SW2 small cell lung cancer cells were cultured in Dulbecco's modified Eagle's medium (without sodium pyruvate, with 4.5 mg/liter glucose, with pyridoxine HCl) (Life Technologies, Inc.) supplemented with 10% fetal calf serum and 100 IU/ml penicillin/ streptomycin solution at 37°C. NIH/3T3 cells (ATCC number CRL-1658) were cultured in Dulbecco's modified Eagle's medium supplemented with 10% calf serum (Life Technologies, Inc.; lot number 1022174) and 100 IU/ml penicillin/streptomycin solution. All cells were cultivated at 37°C in a humidified atmosphere of 5% CO 2 in air.
For production of stable cell lines, cells were transfected using FuGene6 transfection reagent (Roche Molecular Biochemicals) according to the manufacturer's protocol and selected 72 h post-transfection in the presence of 125 g/ml zeocin. Monoclonal cell lines were established by FACS-mediated cell sorting using a FACStar Plus sorter (Becton Dickinson, San Jose, CA) and subsequent screening by Western blot analysis.
Preparation of Cell Extracts-For preparation of whole cell extracts, cells were washed with ice-cold phosphate-buffered saline and scraped in ice-cold Nonidet P-40 extraction buffer (50 mM Hepes, pH 7.4, 150 mM NaCl, 25 mM ␤-glycerophosphate, 25 mM NaF, 5 mM EGTA, 1 mM EDTA, 1% Nonidet P-40, 10 g/ml leupeptin, 10 g/ml aprotinin, 1 mM phenylmethylsulfonyl fluoride, 1 mM sodium orthovanadate). Suspensions were homogenized using a 23-gauge needle and incubated 5 min on ice, and the lysates were centrifuged at 23,000 ϫ g for 15 min at 4°C. For preparation of cytosolic and nuclear extracts, cells were washed with ice-cold phosphate-buffered saline and scraped in ice-cold hypotonic buffer (10 mM KCl, 20 mM Hepes, pH 7.0, 1 mM MgCl 2 , 0.5 mM dithiothreitol, 0.1% Triton X-100, 20% glycerol, 0.1 mM EGTA, 1 mM sodium orthovanadate, 5 M ␤-glycerophosphate, 5 mM sodium fluoride, 1 mM phenylmethylsulfonyl fluoride, 10 g/ml aprotinin, and 10 g/ml leupeptin). Cells were disrupted using a glass homogenizer (Dounce; 20 strokes, pestle B) on ice and centrifuged at 800 ϫ g for 5 min at 4°C. The supernatant (cytoplasmic fraction) was recovered, while the pellets (nuclear fraction) were resuspended in ice-cold extraction buffer (hypotonic buffer containing 300 mM NaCl) and homogenized using a 23-gauge needle. After incubation on ice for 30 min, samples were centrifuged for 15 min at 23,000 ϫ g at 4°C. Protein concentrations were determined using a Bradford assay (Bio-Rad).
For cell lysates from mouse tissues, organs from a 7-week-old BALB/c female mouse were frozen in liquid nitrogen and ground to a fine powder. Proteins were extracted by resuspending in Nonidet P-40 buffer and processed as described above.
In Vitro Transcription and Translation-In vitro transcription and translation of cyclin A was performed using plasmids pcDNA3-CycA-WT-AU5 (encoding wild type cyclin A) and pcDNA3-CycA-mut5-AU5 (encoding the T69A/R70A cyclin A mutation) (26) and a coupled reticulocyte lysate system (TNT, Promega) in volumes of 50 l. [ Flow Cytometric Analysis-Cells were detached with trypsin-EDTA and washed twice with ice-cold phosphate-buffered saline, and 1 ϫ 10 6 cells were resuspended in 500 l of cold phosphate-buffered saline. To this suspension, 12 l of RNase A (10 mg/ml), 60 l of propidium iodide (50 g/ml in 50 mM sodium citrate, pH 7.6), and 115 l of lysis buffer (0.75% Nonidet P-40, 5 mM EDTA, 5 mM EGTA, 0.1ϫ YOPRO buffer) were added (5ϫ YOPRO buffer: 100 mM sodium citrate, pH 4.0, 134 mM NaCl). Cells were lysed on ice in the dark for 30 min prior to FACS analysis. Propidium iodide-mediated fluorescence is proportional to the cellular DNA content based on the stoichiometric affinity of this DNAintercalating dye. All FACS analyses were performed on a FACStar Plus using the CellQuest TM software (Becton-Dickinson, San Jose, CA). Immunoprecipitation and Western Blot Analysis-For immunoprecipitations, equal amounts of protein were incubated with specific antibodies for 2 h on ice. Immune complexes were collected with protein A-or protein G-Sepharose (Sigma) and washed three times with Nonidet P-40 extraction buffer (see above). Precipitated proteins were released by boiling in sample buffer and subsequent SDS-polyacrylamide gel electrophoresis (SDS-PAGE). The proteins were blotted onto polyvinylidene difluoride membranes (Roche Molecular Biochemicals). After blocking with 20% horse serum (Life Technologies, Inc.) in TTBS (50 mM Tris, pH 7.5, 150 mM NaCl, 0.05% Tween 20), filters were probed with specific antibodies. Proteins were visualized with peroxidase-coupled secondary antibody using the ECL detection system (Amersham Pharmacia Biotech). Stripping of membranes was performed in SDS buffer (62.5 mM Tris, pH 6.8, 2% SDS, 100 mM ␤-mercaptoethanol) for 30 min at 60°C; membranes were then washed in TTBS and reprobed with the indicated antibodies. The antibodies used in this study were cyclin A (clones CYA06, E23, and E72 from NeoMarkers; H-432 sc-751 from Santa Cruz Biotechnology, Inc., Santa Cruz, CA); cyclin B1 (clone V152, NeoMarkers); cyclin E (PC135, Oncogene); p107 (clone SD9, NeoMarkers); Cdk2 (sc-163, Santa Cruz Biotechnology); tubulin-␣ (clone DM1A, NeoMarkers); and p27 Kip1 (K25020, Transduction Laboratories).
RESULTS

Presence of a Truncated Cyclin A Isoform (cyclin A t ) in Cultured Mammalian Cells and Mouse Tissues-Various cell lines
were analyzed for the presence of cyclin A isoforms by immunoblotting using cyclin A-specific antibodies. Cells were seeded at a density of 1.3 ϫ 10 4 cells/cm 2 , and protein extracts were prepared when cultures reached exponential growth phase. In Chinese hamster ovary (CHO-K1) cells, Hs68 primary human fibroblasts, U2-OS human osteogenic sarcoma cells, HuT12 transformed human fibroblasts, and human A431 vulval carcinoma cells, a fast migrating band of 55 kDa was detected in addition to the 60-kDa band corresponding to full-length cyclin A, whereas in NIH/3T3 cells, A549 lung adenocarcinoma cells, PC3 prostatic carcinoma cells, and SW2 small cell lung cancer cells only full-length cyclin A was present (Fig. 1A) . The specificity of the fast migrating band was confirmed by using two different cyclin A-specific antibodies. Thus, this band presumably represents a truncated form of cyclin A that will be further referred to as cyclin A t . Cyclin A t appears to be of the same size in all analyzed cell lines, and the difference in size compared with full-length cyclin A was estimated to be 5 kDa. Among all cell lines analyzed, cyclin A t was most predominant in CHO-K1 cells and generally of low abundance in fast growing transformed cells.
To analyze cyclin A isoforms in tissues, protein lysates were prepared from female liver, kidney, heart, and thymus of BALB/c mice. High expression of cyclin A and a smaller isoform were found in thymus and, at a lower level, in heart extracts (Fig. 1B) . Specific bands corresponding to cyclin A could not be detected in the other tissues tested (data not shown). As seen in NIH/3T3 cells, full-length murine cyclin A appears to migrate faster compared with full-length hamster cyclin A (CHO-K1 control). In addition, a fast migrating specific band corresponding to the size of cyclin A t in CHO-K1 lysates could be detected. These results indicate that truncated isoforms of cyclin A are expressed in specific mouse tissues.
Cyclin A t Is Induced by Culture Age and Cell Density in CHO-K1 Cells-Due to the abundance of cyclin A t in CHO-K1 extracts, the cyclin A isoforms of this cell line were analyzed in greater detail. CHO-K1 cells were seeded at a concentration of 0.25 ϫ 10 4 cells/cm 2 and grown to confluence without medium exchange. Protein extracts were prepared at different times of cultivation at which the cell number was measured in parallel. Western blot analysis revealed the following cyclin A isoform pattern. High levels of full-length cyclin A were present at early stages of cultivation and decreased when cells became confluent. 100 h postseeding, at a density of 23 ϫ 10 4 cells/cm 2 , full-length cyclin A was no longer detectable. Cyclin A t demonstrated a completely different pattern with low levels at early time points, increasing to reach a maximum 100 h post seeding ( Fig. 2A) . Cyclin B and Cdk2 levels remained constant during the entire time course.
The shift in the ratio of full-length and truncated cyclin A, observed when CHO-K1 cells were grown to confluence without medium change, could result from various effects such as cell density, accumulation of extracellular matrix proteins, or cell death (apoptosis and/or necrosis). In order to determine the influence of cell density on the cyclin A isoform profile, CHO-K1 cells were seeded at three different concentrations, and cell extracts were prepared at 12 and 21 h post seeding. The level of full-length cyclin A remained constant with increasing cell density up to 24 ϫ 10 4 cells/cm 2 (Fig. 2B) . However, the cyclin A t isoform increased with higher cell densities. This experiment points to an influence of cell density on the abundance of cyclin A t in CHO-K1 cells independent of the length of cultivation. A similar correlation between culture confluence and cyclin A isoform profile was found in U2-OS cells (data not shown).
CHO-K1 Cell Lysates Induce Cleavage of in Vitro Translated
Cyclin A-In order to characterize the cyclin A cleavage activity of CHO-K1 cells, radiolabeled in vitro translated human cyclin A was incubated with whole cell extracts from CHO-K1 and NIH/3T3 cells and analyzed by SDS-PAGE. In contrast to NIH/3T3 extracts, CHO-K1 extracts contain a proteolytic activity that results in cleavage of full-length cyclin A, yielding a product of 55 kDa (Fig. 3) . Cyclin A residues Thr 69 and Arg 70 have previously been reported to be essential for cleavage by in vitro translated p27 Kip1 , since T69A/R70A (harboring Thr to Ala and Arg to Ala mutations) were refractory to p27
Kip1 -mediated cleavage (26) . However, incubation of the T69A/R70A cyclin A mutant with whole cell CHO-K1 extracts gave rise to the same cleavage product seen for the wild type protein (Fig.  3) . These data indicate that cyclin A t results from proteolytic cleavage by a mechanism that differs from the truncation phenomenon described by Bastians et al. (26) .
Cyclin A Is Cleaved at the N Terminus in CHO-K1 Cells-In order to locate the processing site within cyclin A, a CHO-K1 cell line was established that stably expresses cyclin A containing an HA tag at its N terminus. The monoclonal cell line HR1 was generated by stable transfection of pRC/CMV-cycA-HA, a pRC/CMV expression vector (Invitrogen) containing HA-tagged human cyclin A under the control of the P CMV promoter. HR1 cells were seeded at a concentration of 0.67 ϫ 10 4 cells/cm 2 . Protein extracts were prepared after the indicated times and analyzed by immunoblotting using HA-and cyclin A-specific antibodies. Fig. 4 shows that the cyclin A-specific antibody detects both cyclin A isoforms, whereas antibodies directed against the HA epitope react only with the full-length protein.
These results clearly demonstrate that cleavage of cyclin A occurs at the N terminus in cultured CHO-K1 cell. kinase inhibitor p27
Kip1 induces cleavage of cyclin A in cultured cells as suggested by previous in vitro data (26) . XM113-6 cells express p27
Kip1 under the control of the tetracyclineresponsive promoter (P hCMV*-1 ). When cells are grown in the absence of tetracycline, p27
Kip1 expression is induced, and cells arrest in the G 1 phase of the cell cycle (27, 28) . 0.67 ϫ 10 4 XM113-6 cells/cm 2 were seeded into tetracycline-containing medium. After 24 h, the medium was replaced by tetracyclinefree medium in half of the cultures, and extracts were prepared at indicated times (Fig. 5) . As shown in Fig. 5 , cyclin A t levels were not increased following induction of p27 Kip1 expression. However, the overall expression levels of both cyclin A isoforms decreased 24 h after induction of p27 Kip1 , which is consistent with G 1 phase-specific down-regulation of cyclin A (29) . Based on these experiments, p27
Kip1 is unlikely to be involved in cyclin A truncation.
N-terminal Cleavage of Cyclin A Is Proteasome-independent and Occurs upon S Phase
Entry-Cyclins are proteolytically degraded at different stages of the cell cycle via the ubiquitin pathway. Usually, degradation by the ubiquitin proteolytic system leads to complete degradation of the target protein. NF-B is an exception, since it is only partially degraded at the C terminus by the 26 S proteasome (30) . Furthermore, it has been shown that the 26 S proteasome initiates cyclin B degradation by restricted digestion, resulting in an N-terminally truncated form, which appears transiently upon activation of fish eggs (31) .
To determine whether the 26 S proteasome is involved in the proteolytic cleavage of cyclin A, CHO-K1 cells were seeded at different densities and cultivated in the presence of the proteasome inhibitor N-acetyl-leucinyl-leucinyl-norleucinal (LLnL) for 5 h. Western blot analysis showed no influence of LLnL on the cyclin A profile (full-length versus truncated form), which suggests that the proteasome is not involved in the process of cyclin A t -specific truncation (Fig. 6) . In mammalian cells, cyclin A expression is induced during the onset of S phase. To assess any possible variations of cyclin A t levels as the cells passage through the cell cycle, cyclin A isoforms were analyzed in synchronized Hs68 cells. The cells were synchronized by release from serum starvation and lysed at different times following the addition of serum to the medium, and extracts were analyzed by immunoblotting. FACS analysis confirmed that the cells were successfully synchronized. Maximal expression levels of full-length cyclin A are observed 18 -20 h after release from serum starvation. Similar to the full-length protein, cyclin A t appears to be absent in G 1 phase cells. The increase in cyclin A t occurs when cells enter S phase with a significant delay compared with cyclin A protein levels (Fig. 7) . These results confirm that cyclin A t is a cleavage product of the full-length protein and demonstrate that cleavage occurs as soon as cyclin A is expressed at the G 1 /S transition.
Differential Subcellular Localization of Cyclin A IsoformsDifferential subcellular localization of key regulatory molecules is a common theme in cell cycle control, exemplified by shuttling of cyclin B between the nucleus and the cytoplasm at the G 2 /M transition (32) . In anchorage-independent fibroblasts, p21 and p27
Kip1 are sequestered away from the nucleus by cytoplasmic cyclin E-Cdk2 complexes, thereby resulting in active nuclear Cdk2. Thus, cytoplasmic displacement of cyclindependent kinase inhibitors may play a role in transformation and oncogenesis (33) . Studies in mammalian cells using immunostaining and fractionated extracts showed that cyclin A is located predominantly in the nucleus, from expression in G 1 phase to degradation in the M phase (34). To analyze the subcellular localization of the cyclin A isoforms, fractionated extracts of CHO-K1 cells were prepared. As expected, fulllength cyclin A was restricted almost entirely to the nucleus. Interestingly, cyclin A t was detected almost exclusively in the cytoplasm (Fig. 8) . The membrane was reprobed using an ␣-tubulin-specific antibody to confirm the quality of fractions. These data suggest that N-terminal cleavage of cyclin A results in redistribution of cyclin A t to the cytoplasm. Cyclin A t Binds Cdk2 in CHO-K1 Cells-Cyclin A forms complexes with several key cell cycle-regulatory molecules, such as the transcription factor E2F, the Rb-related protein p107, the protein kinase Cdk2, and the cell cycle inhibitor p27
Kip1 (35) (36) (37) (38) . We tested whether cyclin A t retains its ability to interact with Cdk2. CHO-K1 cells were seeded at densities of 2 ϫ 10 4 , 4 ϫ 10 4 , and 8 ϫ 10 4 cells/cm 2 , and whole cell extracts were prepared after 24 h. Cdk2 was immunoprecipitated, and immune complexes were resolved by SDS-PAGE and analyzed for the presence of cyclin A isoforms by immunoblotting (Fig.   FIG. 3. Cyclin A is cleaved by CHO-K1 
FIG. 4. Cyclin A
t represents an N-terminally truncated isoform of cyclin A. HR1 expressing heterologous N-terminally HA-tagged cyclin A were cultivated as described in Fig. 2A . Lysates were prepared at indicated cell densities, and equal amounts of protein were analyzed by immunoblotting using antibodies directed against the HA epitope and cyclin A.
FIG. 5. p27
Kip1 does not induce cyclin A cleavage in CHO-K1 cells. XM113-6 cells were grown for 24 h in the presence of 2.5 g/ml tetracycline before medium was replaced by tetracycline-free medium in half of the cultures. Lysates were prepared at indicated times, and equal amounts of protein were analyzed by immunoblotting using antibodies specific for cyclin A and p27.
9A). Whole cell extracts used for immunoprecipitation were analyzed in parallel for cyclin A/cyclin A t levels. Fig. 9A shows that cyclin A t is capable of interacting with Cdk2, and in fact it appears to be the abundant cyclin A isoform in the immunocomplex. Since cyclin A t is predominantly found in the cytoplasmic fraction in CHO-K1 cells (Fig. 8) , we next sought to determine whether Cdk2-cyclin A t complexes exist in this cellular compartment. We assayed for the assembly of Cdk2-cyclin A t complexes by anti-Cdk2 immunoprecipitation followed by anti-cyclin A immunoblotting. Fig. 9B shows a specific interaction of cyclin A t and Cdk2 in the cytoplasm of CHO-K1 cells.
DISCUSSION
Cyclins are key factors for proliferation of eukaryotic cells due to their association with and activation of Cdks. Kinase activity of different cyclin-Cdk complexes is restricted to specific stages of the cell cycle and can be inhibited by appropriate phosphorylation events or by the binding of inhibitory proteins. Cyclin A forms complexes with Cdk2 and Cdk1, which are required for DNA replication (initiation of S phase) and induction of mitosis, respectively (1) . Cyclin A synthesis is initiated in late G 1 phase, and the protein is degraded by APC during prophase (22) . Here an N-terminally truncated form of cyclin A, designated cyclin A t , was characterized in vitro, in cultured mammalian cells, and in vivo, and the data presented suggest Cytoplasmic (Cyto.) and nuclear (Nucl.) extracts were prepared after 48 h, and equal parts were analyzed by immunoblotting using antibodies specific for cyclin A. The blots were reprobed using an anti-␣ tubulin antibody to monitor the quality of fractionation.
FIG. 9.
Interaction of cyclin A with Cdk2. A, CHO-K1 cells were seeded at three different densities (low density (LD), medium density (MD), and high density (HD)), and whole cell lysates were prepared after 24 h. Cdk2 was immunoprecipitated (IP), and immune complexes were subjected to SDS-PAGE and analyzed using cyclin A-and Cdk2-specific antibodies. Whole cell lysates (WCE) were loaded as control. B, CHO-K1 cells were seeded at high density, and cytoplasmic (Cyto.) extracts were prepared after 24 h. Cdk2 was immunoprecipitated (IP) from cytoplasmic extracts, and immune complexes were subjected to SDS-PAGE and analyzed by cyclin A-and Cdk2-specific antibodies. Cytoplasmic extract was loaded in lane 3. In addition, a nonrelated control antibody (cIAP-2) was included to demonstrate the specificity of the interaction (lane 1).
that proteolytic cleavage of this mitotic cyclin is relevant in vivo.
Screening of several cell lines, mammalian primary cells and mouse tissues by immunoblotting revealed a small cyclin A isoform (cyclin A t ) that was especially abundant in CHO-K1 but was undetectable in other cell types such as NIH/3T3 cells. The presence of cyclin A t in primary human fibroblasts (Hs68) and mouse thymus demonstrates that this isoform of cyclin A is not restricted to cultured cell lines. Cyclin A t migrates at ϳ55 kDa on SDS gels, and incubation of in vitro translated cyclin A with cell extracts revealed a proteolytic activity present in CHO-K1 but not in NIH/3T3 cells, which resulted in a 55-kDa cyclin A cleavage product. This suggests that cyclin A t is a proteolytically processed isoform of cyclin A. Furthermore, overexpression of HA-tagged cyclin A showed cleavage to occur at the N terminus.
At least two distinct mechanisms appear to modulate cyclin A cleavage in long term cultivations: (i) culture age and (ii) cell density (Fig. 2) . (i) When CHO-K1 cells grow to high densities without changing the culture medium, full-length cyclin A levels drop significantly at late cultivation stages in comparison with cyclin A t levels, which increase steadily over time ( Fig.  2A) . It has to be noted that CHO-K1 cells are not contactinhibited, and even at high cell densities when full-length cyclin A was no longer detectable cells divided and expressed cyclin B (Fig. 2A). (ii) Cell density dependence of cyclin A t appearance could be shown in CHO-K1 cells and in the human osteogenic sarcoma cell line U2-OS, which suggests that this phenomenon is widespread among mammalian cell lines. However, while high density leads to increased levels of cyclin A t , full-length cyclin A levels do not appear to be affected significantly (Fig. 2B) . This indicates an additional, unknown mechanism by which complete degradation of full-length cyclin A occurs in cells that are cultured for extended periods without medium change.
A cleavage mechanism for cyclin A proposed by Bastians et al. (26) based on in vitro assays required the activity of the cyclin-dependent kinase inhibitor p27 Kip1 . Using the stable CHO-K1-derived cell line XM113-6 that expresses p27
Kip1 under the control of the tetracycline-responsive promoter (P h -CMV*-1; Refs. 27, 28, and 39), we showed that induction of p27 Kip1 did not alter the cyclin A/cyclin A t profile. Conditional p27
Kip1 expression results in G 1 -specific growth arrest of XM113-6 cells (28), and cyclin A expression is transcriptionally repressed in this cell cycle phase (34). Consequently, total cyclin A levels were significantly lower in extracts prepared 24 h after induction of p27 Kip1 (absence of tetracycline) compared with G 1 -arrested cells (p27 Kip1 expression unit repressed by the addition of tetracycline). However, the ratio between full-length and truncated cyclin A remained unaffected even shortly after p27
Kip1 induction before cells accumulated in G 1 phase. Therefore, p27
Kip1 does not seem to be involved in Nterminal truncation of cyclin A. This fact is supported by a recent publication issued during revision of this manuscript, which demonstrates that the p27
Kip1 -mediated cleavage of cyclin A reported by Bastians et al. (26) was due to a bacterial OmpT protease contamination in p27
Kip1 -encoding plasmid preparations used for in vitro translation of this cyclin-dependent kinase inhibitor (40) . Since the cyclin A mutant (T69A/ R70A; Ref. 26 ) that is resistant to OmpT cleavage is still processed by CHO-K1 extracts, the cleavage site targeted by proteolytic activities found in CHO-K1 extracts is different from the OmpT recognition site.
Ubiquitin-mediated proteolysis usually leads to complete degradation of targeted molecules. One exception is provided by the transcriptional regulator NF-B. The precursor protein of NF-B, p105, is processed in a limited manner; the C terminus is degraded, whereas the N terminus yields a stable product, p50 (30) . It appears that a glycine-rich region interferes with the 26 S proteasome, inhibiting complete degradation and stabilizing p50. Similarly, cyclin A t might be the product of a partial 26 S proteasome-mediated degradation. However, LLnL-based proteasome inhibition experiments exclude the involvement of the general protein degradation machinery in the truncation of cyclin A. Our results also exclude the possibility that cyclin A t is an intermediate cleavage product of 26 S degradation as has been described for cyclin B (31). Thus, a 26 S proteasome-independent proteolytic mechanism appears to be responsible for the truncation of cyclin A.
In synchronized human primary cells, cyclin A truncation is cell cycle-dependent. Similar to full-length protein levels, cyclin A t levels increase when cells enter S phase. However, this increase appears to be delayed compared with induction of full-length cyclin A. These data confirm that cyclin A t is a proteolytic cleavage product and suggest that a yet to be identified protease is active during S phase.
Cyclin A is predominantly localized to the nucleus (41) . Fractionated extracts were used to assess whether the N terminus is involved in the subcellular localization of cyclin A. Our results show that cyclin A t is mainly found in the cytoplasm. The 70-amino acid-long N terminus may either contain a nuclear localization signal or promote folding of cyclin A into a conformation that is competent for nuclear translocation. Recent studies showed that the cyclins A and D1, and the cyclin-dependent kinase inhibitor p21 are not expressed in normal renal tissue, whereas tumor cells stained positively for these cell cycle regulators. Interestingly, all three proteins were detected in the nucleus, but cyclin A was also found in the cytoplasm (42) .
In this report, we show that cyclin A t can interact with Cdk2. Cdk2-cyclin A complexes are required for G 1 /S transition (38) .
In immunoprecipitation experiments, we show the interaction of cyclin A t and Cdk2 in the cytoplasm of CHO-K1 cells. It is tempting to speculate that the biological function of cyclin A t may involve complex formation with cyclin A binding partners, thereby competing with the full-length cyclin A isoform. Our data suggest that protein complexes containing cyclin A t are located in the cytoplasm, whereas those containing full-length cyclin A reside in the nucleus. This different subcellular localization could serve to sequester cyclin-dependent kinase complexes away from the nucleus where they promote cell cycle progression. Proteolytic cyclin A cleavage could thereby act as a novel control mechanism that becomes activated once cyclin A expression has reached maximal levels in cells progressing through S phase.
Aberrant expression of cyclins has been found in a number of human cancers. Especially, cyclin A can be considered as a marker for tumor cell proliferation (43, 44) . Analysis of cyclin A expression profiles of patients suffering from colorectal carcinoma, soft tissue sarcoma, and smooth muscle tumors of the uterus showed that cyclin A expression in tumor cells correlates with a low survival rate. Thus, cyclin A overexpression can be used as a marker for poor prognosis and poor metastasis-free survival (45) (46) (47) . There is some evidence that the presence of truncated cyclin isoforms is characteristic to some tumors (48) . Studies in breast cancer cells showed the presence of multiple cyclin E isoforms resulting from truncations in tumors that were not observed in normal tissues (49) . These isoforms are able to form complexes with Cdks that retain kinase activity. Among the screened cell lines, some tumor-derived cell lines such as U2-OS and HuT12 showed low levels of the cyclin A t isoform, whereas in fast growing, transformed cells such as
